Skip to main content

Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy

Publication ,  Conference
Nelson, C; Wu, Y; Gemberling, M; Oliver, M; Bohning, JD; Robinson-Hamm, JN; Bulaklak, K; Rivera, RMC; Collier, JH; Asokan, A; Gersbach, CA
Published in: MOLECULAR THERAPY
April 22, 2019

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

46 / 47

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nelson, C., Wu, Y., Gemberling, M., Oliver, M., Bohning, J. D., Robinson-Hamm, J. N., … Gersbach, C. A. (2019). Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy. In MOLECULAR THERAPY (Vol. 27, pp. 46–47). Washington, DC: CELL PRESS.
Nelson, Christopher, Yaoying Wu, Matthew Gemberling, Matthew Oliver, Joel D. Bohning, Jacqueline N. Robinson-Hamm, Karen Bulaklak, et al. “Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy.” In MOLECULAR THERAPY, 27:46–47. CELL PRESS, 2019.
Nelson C, Wu Y, Gemberling M, Oliver M, Bohning JD, Robinson-Hamm JN, et al. Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 46–7.
Nelson, Christopher, et al. “Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 46–47.
Nelson C, Wu Y, Gemberling M, Oliver M, Bohning JD, Robinson-Hamm JN, Bulaklak K, Rivera RMC, Collier JH, Asokan A, Gersbach CA. Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy. MOLECULAR THERAPY. CELL PRESS; 2019. p. 46–47.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

46 / 47

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences